LoginSignup
IDI

Idorsia Stock

StockStock
ISIN: CH0363463438
Ticker: IDIA
CH0363463438
IDIA

Price

Historical dividends and forecast

All dividend data

 

$12.15

CHART BY

Frequently asked questions

What is Idorsia's market capitalization?

The market capitalization of Idorsia is $195.30M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Idorsia?

Idorsia's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$1.899. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Idorsia's stock?

Currently, 9 analysts cover Idorsia's stock, with a consensus target price of $1.923. Analyst ratings provide insights into the stock's expected performance.

What is Idorsia's revenue over the trailing twelve months?

Over the trailing twelve months, Idorsia reported a revenue of $83.61M.

What is the EBITDA for Idorsia?

Idorsia's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$423.87M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Idorsia?

Idorsia has a free cash flow of -$550.89M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Idorsia's stock?

The 5-year beta for Idorsia is 2.13. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Idorsia have, and what sector and industry does it belong to?

Idorsia employs approximately 938 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Idorsia's shares?

The free float of Idorsia is 112.05M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $195.30M

5Y beta

 2.13

EPS (TTM)

 -$1.899

Free Float

 112.05M

Revenue (TTM)

 $83.61M

EBITDA (TTM)

 -$423.87M

Free Cashflow (TTM)

 -$550.89M

Pricing

1D span
$1.028$1.103

Analyst Ratings

The price target is $1.923 and the stock is covered by 9 analysts.

Buy

0

Hold

4

Sell

5

Information

Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

938

Biotechnology & Drugs

Health Care

Identifier

ISIN

CH0363463438

Primary Ticker

IDIA

Knockouts

Join the conversation
Sign upLogin